Artemis Medicare Services reports 12.7% rise in consolidated revenue for Q1 FY27; Profit jumps 48.3%

Artemis Medicare Services reports 12.7% rise in consolidated revenue for Q1 FY27; Profit jumps 48.3%

Artemis Medicare Services reports 12.7% rise in consolidated revenue for Q1 FY27; Profit jumps 48.3%​

Artemis Medicare Services Ltd has reported its financial results for the first quarter of fiscal year 2027, with the company recording a consolidated increase in revenue from operations and significant growth in profit.

For the quarter ended June 30, 2026, Artemis Medicare Services Ltd registered a revenue from operations of Rs 28,732 Lacs, marking a 12.7% rise compared to the same period in the previous fiscal year.

Consolidated Financial Performance (Q1 FY27 vs Q1 FY26)​

The consolidated performance highlights for Artemis Medicare Services Ltd are presented below:

MetricQ1 FY27Q1 FY26Growth
Revenue from OperationsRs 28,732 LacsRs 25,496 Lacs12.7%
EBITDARs 6,182 LacsRs 4,832 Lacs27.9%
PATRs 3,144 LacsRs 2,120 Lacs48.3%
Diluted EPSRs 1.98Rs 1.3546.7%

Hospital Gurgaon Performance Highlights​

The performance of the Artemis hospital in Gurgaon showed strong growth across key metrics compared to Q1 FY26:

MetricQ1 FY27 (Gurgaon)Q1 FY26 (Gurgaon)
Revenue from OperationsRs 27,849 LacsRs 24,125 Lacs
EBITDARs 6,163 LacsRs 4,953 Lacs
PATRs 3,306 LacsRs 2,491 Lacs
Bed Capacity Utilisation65.7%61.2%
Average Revenue Per Occupied Bed (ARPOB)Rs 85,690Rs 79,752

Revenue from overseas patients at the Gurgaon hospital increased by 8.6%, reaching Rs 7,651 Lacs from Rs 7,043 Lacs and contributing 27.5% to Revenue from operations.

Quarterly Trends (Q1 FY27 vs Q4 FY26)​

Looking at quarter-on-quarter comparisons against the previous quarter, the company's performance trends are as follows:

MetricQ1 FY27Q4 FY26Growth
Revenue from OperationsRs 28,732 LacsRs 27,923 Lacs2.9%
EBITDARs 6,182 LacsRs 5,938 Lacs4.1%
PATRs 3,144 LacsRs 3,028 Lacs3.8%
Diluted EPSRs 1.98Rs 1.904.2%

The Gurgaon hospital demonstrated consistent operational improvements quarter-on-quarter (QoQ), with revenue from operations rising by 4.1% to Rs 27,849 Lacs against Rs 26,746 Lacs. Bed capacity utilisation stood at 65.7%, up from 64.6%.

Management Commentary and Strategic Expansion​

Onkar Kanwar, Chairman of Artemis Medicare Services Ltd, commented on the results, stating that the company commenced FY27 with a strong note, delivering consistent growth across financial and operating metrics. He noted that this robust performance reflects the resilience and disciplined execution of the business model.

Mr. Kanwar highlighted the continued good performance of the flagship Gurugram hospital, supported by improved occupancy and higher average revenue per occupied bed (ARPOB), alongside sustained demand for specialized clinical services. A key milestone mentioned was the commencement of operations at the Raipur hospital in July 2026, marking a significant step in expanding Artemis' presence into high-growth markets beyond its flagship center.

Dr. Devlina Chakravarty, Managing Director, added that Q1 FY27 reflected operational strategy strength through healthy revenue growth, improved margins, and strong profitability. She stressed that the focus on clinical quality and disciplined cost management enabled financial enhancement while keeping patient care central to operations. Dr. Chakravarty also confirmed the start of operations at the Raipur hospital in July 2026, noting that this facility will be instrumental in strengthening specialized services and establishing a trusted healthcare destination in Central India as it ramps up.

Artemis Medicare Services Ltd operates over 800 beds predominantly in the Delhi NCR region, including a 700+ bed quaternary care super speciality hospital. The company also maintains a joint venture with Philips under the Artemis Cardiac Care brand and has an operational presence in Mauritius through an operations and management arrangement.

ARTEMISMED Stock Price Movement​

Artemis Medicare Services Limited stock closed today in solid gains, climbing by 1.21% to settle at ₹302.2.The shares saw robust activity with a traded volume of 261,601, reflecting a strong performance near the company's annual high range.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:
Back
Top